Back to Gastroenterology
Gastroenterologyv2005Evidence-Based

Glasgow Alcoholic Hepatitis Score (GAHS)

Prognostic score for mortality prediction in patients with alcoholic hepatitis using five clinical variables: age, white blood cell count, urea, prothrombin time ratio, and bilirubin. More accurate than the modified Discriminant Function for predicting 28-day mortality

Clinical Input Parameters

years
Range: 18 — 120 years
×10⁹/L
Range: 1 — 100 ×10⁹/L
mmol/L
Range: 1 — 50 mmol/L
ratio
Range: 0.8 — 10 ratio
μmol/L
Range: 10 — 1000 μmol/L
Clinical Assessment
Awaiting Parameters
gahs score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Glasgow Alcoholic Hepatitis Score (GAHS) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Score = Age points + WBC points + Urea points + PT ratio points + Bilirubin points. Total range: 5-12 points. Cutoff: ≥9 indicates high mortality risk

Clinical Pearls & Practice Notes

  • Developed from analysis of 241 patients with alcoholic hepatitis
  • More accurate than modified Discriminant Function (mDF) for mortality prediction
  • Overall accuracy: 81% on day 1, 93% on day 7 for predicting 28-day outcome
  • Sensitivity: 81% (day 1), 93% (day 7); Specificity: 61% (day 1), 68% (day 7)
  • First scoring system to include inflammatory parameter (WBC count)
  • Score ≥9 identifies patients who benefit from corticosteroid treatment
  • Urea preferred over creatinine due to bilirubin interference with creatinine assays
  • 28-day survival: 87% for GAHS <9, 46% for GAHS ≥9 (untreated), 78% for GAHS ≥9 (treated)
  • Validated across different patient populations and healthcare settings
  • Should be used in conjunction with comprehensive clinical assessment
  • Consider contraindications to corticosteroids before treatment initiation

Evidence & Literature Citations

  1. Forrest EH, Evans CD, Stewart S, et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut. 2005;54(8):1174-1179. doi: 10.1136/gut.2004.050781.
  2. Louvet A, Naveau S, Abdelnour M, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007;45(6):1348-1354. doi: 10.1002/hep.21607.
  3. Forrest EH, Morris AJ, Stewart S, et al. The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids. Gut. 2007;56(12):1743-1746. doi: 10.1136/gut.2006.099226.

Score Interpretation Ranges

Low Risk5 – 8 pts

Good prognosis

High Risk9 – 12 pts

Poor prognosis

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.